Newsroom
Return to U.S. Market
FOR RELEASE Wednesday, April 27, 2005
ROCHESTER, N.Y. - Paul G. Howes, president of Bausch & Lomb North America, (left) delivers the first PureVision trial lens set to Rochester optometrist Dr. Michael DePaolis. The Company's innovative silicone hydrogel lens will be available in the United States once again, following the recent successful resolution of a patent dispute. "The PureVision lens design provides wearers exceptional vision, health and comfort, whether the lenses are removed each day or worn 30 days straight, including overnight," said Howes. Eye doctors across the U.S. soon will receive the sets, containing a range of PureVision lens prescription powers, to help fit their patients. More information is available at www.purevision.com.
Two high-resolution photos are available for download on the Business Wire site, at this URL: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=4873881
Bausch & Lomb is the eye health company, dedicated to perfecting vision and enhancing life for consumers around the world. Its core businesses include soft and rigid gas permeable contact lenses and lens care products, and ophthalmic surgical and pharmaceutical products. The Bausch & Lomb name is one of the best known and most respected healthcare brands in the world. Founded in 1853, the Company is headquartered in Rochester, New York. Bausch & Lomb's 2004 revenues were $2.2 billion; it employs approximately 12,400 people worldwide and its products are available in more than 100 countries. More information about the Company can be found on the Bausch & Lomb Web site at www.bausch.com . Copyright Bausch & Lomb Incorporated.
® / TM denote trademarks of Bausch & Lomb Incorporated.
